Sleeve Gastrectomy Improves Hepatic Glucose Metabolism by Downregulating FBXO2 and Activating the PI3K-AKT Pathway

• Published in: International journal of molecular sciences Vol. 24; no. 6; p. 5544
• Main Authors: Chen, Ningyuan, Cao, Ruican, Zhang, Zhao, Zhou, Sai, Hu, Sanyuan
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 14.03.2023; MDPI
• Subjects: Animals; Blood Glucose - analysis; Cell Cycle Proteins - metabolism; Comparative analysis; Dextrose; Diabetes; Diabetes Mellitus, Type 2 - metabolism; F-Box Proteins; Fatty acids; Fatty liver; Food; Gastrectomy; Gastrointestinal surgery; Glucose; Glucose - metabolism; Glucose tolerance tests; Health aspects; High density lipoprotein; Homeostasis; Humans; Insulin; Insulin resistance; Lipids; Liver; Liver diseases; Metabolism; Mice; Nerve Tissue Proteins - metabolism; Obesity; Phosphatidylinositol 3-Kinases - metabolism; Phosphorylation; Physiological aspects; Proteins; Proto-Oncogene Proteins c-akt - metabolism; Remission (Medicine); Type 2 diabetes; Weight control; China; T2DM; SG; glucose metabolism; FBXO2; PI3K-AKT pathway
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms24065544

Type 2 diabetes mellitus (T2DM), a chronic metabolic disease, is a public health concern that seriously endangers human health. Sleeve gastrectomy (SG) can relieve T2DM by improving glucose homeostasis and enhancing insulin sensitivity. However, its specific underlying mechanism remains elusive. SG and sham surgery were performed on mice fed a high-fat diet (HFD) for 16 weeks. Lipid metabolism was evaluated via histology and serum lipid analysis. Glucose metabolism was evaluated using the oral glucose tolerance test (OGTT) and insulin tolerance test (ITT). Compared with the sham group, the SG group displayed a reduction in liver lipid accumulation and glucose intolerance, and western blot analysis revealed that the AMPK and PI3K-AKT pathways were activated. Furthermore, transcription and translation levels of FBXO2 were reduced after SG. After liver-specific overexpression of FBXO2, the improvement in glucose metabolism observed following SG was blunted; however, the remission of fatty liver was not influenced by the over expression of FBXO2. Our study explores the mechanism of SG in relieving T2DM, indicating that FBXO2 is a noninvasive therapeutic target that warrants further investigation.